MedicaidCoverageHigh impact
Nebraska Medicaid: Knee injection coverage and attestation for single-dose drugs
UnitedHealthcare·NE · Orthopedics, Rheumatology, Pain Management +2 more·State news
Effective date
Jan 1, 2026
We identified it
Jun 13, 2026
Summary
Effective January 1, 2026, Nebraska Medicaid will discontinue coverage for all hyaluronan knee injections due to lack of medical necessity evidence. Additionally, providers must now use modifier JZ when billing single-dose drugs with no wastage and document any discarded amounts in medical records.
Action Required
By January 1, 2026: Billing team must update system to deny all hyaluronan knee injection claims (HCPCS J7320-J7332) for Nebraska Medicaid patients as these will no longer be reimbursed. Providers must add modifier JZ to all single-dose drug claims with no wastage and document any discarded amounts in patient medical records. Update encounter forms and billing software rules to prevent claim denials.